American Cancer Society prostate cancer survivorship care guidelines

Ted A. Skolarus, Andrew M D Wolf, Nicole L. Erb, Durado D. Brooks, Brian M. Rivers, Willie Underwood, Andrew L. Salner, Michael J. Zelefsky, Jeanny B. Aragon-Ching, Susan F. Slovin, Daniela A. Wittmann, Michael A. Hoyt, Victoria Sinibaldi, Gerald Chodak, Mandi L. Pratt-Chapman, Rebecca L. Cowens-Alvarado

Research output: Contribution to journalArticle

Abstract

Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases. CA Cancer J Clin 2014;64:225-249.

Original languageEnglish (US)
Pages (from-to)225-249
Number of pages25
JournalCa-A Cancer Journal for Clinicians
Volume64
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Prostatic Neoplasms
Survival Rate
Guidelines
Survivors
Aftercare
Second Primary Neoplasms
Health Promotion
Primary Health Care
Neoplasms
Early Detection of Cancer
Sample Size
Quality of Life
Databases
Recurrence
Health
Therapeutics
Population

Keywords

  • care coordination
  • clinical care
  • follow-up
  • guidelines
  • late effects
  • long-term effects
  • primary care
  • prostate cancer
  • quality of life
  • survivorship
  • survivorship care plan

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., ... Cowens-Alvarado, R. L. (2014). American Cancer Society prostate cancer survivorship care guidelines. Ca-A Cancer Journal for Clinicians, 64(4), 225-249. https://doi.org/10.3322/caac.21234

American Cancer Society prostate cancer survivorship care guidelines. / Skolarus, Ted A.; Wolf, Andrew M D; Erb, Nicole L.; Brooks, Durado D.; Rivers, Brian M.; Underwood, Willie; Salner, Andrew L.; Zelefsky, Michael J.; Aragon-Ching, Jeanny B.; Slovin, Susan F.; Wittmann, Daniela A.; Hoyt, Michael A.; Sinibaldi, Victoria; Chodak, Gerald; Pratt-Chapman, Mandi L.; Cowens-Alvarado, Rebecca L.

In: Ca-A Cancer Journal for Clinicians, Vol. 64, No. 4, 2014, p. 225-249.

Research output: Contribution to journalArticle

Skolarus, TA, Wolf, AMD, Erb, NL, Brooks, DD, Rivers, BM, Underwood, W, Salner, AL, Zelefsky, MJ, Aragon-Ching, JB, Slovin, SF, Wittmann, DA, Hoyt, MA, Sinibaldi, V, Chodak, G, Pratt-Chapman, ML & Cowens-Alvarado, RL 2014, 'American Cancer Society prostate cancer survivorship care guidelines', Ca-A Cancer Journal for Clinicians, vol. 64, no. 4, pp. 225-249. https://doi.org/10.3322/caac.21234
Skolarus TA, Wolf AMD, Erb NL, Brooks DD, Rivers BM, Underwood W et al. American Cancer Society prostate cancer survivorship care guidelines. Ca-A Cancer Journal for Clinicians. 2014;64(4):225-249. https://doi.org/10.3322/caac.21234
Skolarus, Ted A. ; Wolf, Andrew M D ; Erb, Nicole L. ; Brooks, Durado D. ; Rivers, Brian M. ; Underwood, Willie ; Salner, Andrew L. ; Zelefsky, Michael J. ; Aragon-Ching, Jeanny B. ; Slovin, Susan F. ; Wittmann, Daniela A. ; Hoyt, Michael A. ; Sinibaldi, Victoria ; Chodak, Gerald ; Pratt-Chapman, Mandi L. ; Cowens-Alvarado, Rebecca L. / American Cancer Society prostate cancer survivorship care guidelines. In: Ca-A Cancer Journal for Clinicians. 2014 ; Vol. 64, No. 4. pp. 225-249.
@article{b4bf0cfc664b43e7b51d1b8608991994,
title = "American Cancer Society prostate cancer survivorship care guidelines",
abstract = "Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases. CA Cancer J Clin 2014;64:225-249.",
keywords = "care coordination, clinical care, follow-up, guidelines, late effects, long-term effects, primary care, prostate cancer, quality of life, survivorship, survivorship care plan",
author = "Skolarus, {Ted A.} and Wolf, {Andrew M D} and Erb, {Nicole L.} and Brooks, {Durado D.} and Rivers, {Brian M.} and Willie Underwood and Salner, {Andrew L.} and Zelefsky, {Michael J.} and Aragon-Ching, {Jeanny B.} and Slovin, {Susan F.} and Wittmann, {Daniela A.} and Hoyt, {Michael A.} and Victoria Sinibaldi and Gerald Chodak and Pratt-Chapman, {Mandi L.} and Cowens-Alvarado, {Rebecca L.}",
year = "2014",
doi = "10.3322/caac.21234",
language = "English (US)",
volume = "64",
pages = "225--249",
journal = "Ca-A Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - American Cancer Society prostate cancer survivorship care guidelines

AU - Skolarus, Ted A.

AU - Wolf, Andrew M D

AU - Erb, Nicole L.

AU - Brooks, Durado D.

AU - Rivers, Brian M.

AU - Underwood, Willie

AU - Salner, Andrew L.

AU - Zelefsky, Michael J.

AU - Aragon-Ching, Jeanny B.

AU - Slovin, Susan F.

AU - Wittmann, Daniela A.

AU - Hoyt, Michael A.

AU - Sinibaldi, Victoria

AU - Chodak, Gerald

AU - Pratt-Chapman, Mandi L.

AU - Cowens-Alvarado, Rebecca L.

PY - 2014

Y1 - 2014

N2 - Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases. CA Cancer J Clin 2014;64:225-249.

AB - Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases. CA Cancer J Clin 2014;64:225-249.

KW - care coordination

KW - clinical care

KW - follow-up

KW - guidelines

KW - late effects

KW - long-term effects

KW - primary care

KW - prostate cancer

KW - quality of life

KW - survivorship

KW - survivorship care plan

UR - http://www.scopus.com/inward/record.url?scp=84904159542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904159542&partnerID=8YFLogxK

U2 - 10.3322/caac.21234

DO - 10.3322/caac.21234

M3 - Article

C2 - 24916760

AN - SCOPUS:84904159542

VL - 64

SP - 225

EP - 249

JO - Ca-A Cancer Journal for Clinicians

JF - Ca-A Cancer Journal for Clinicians

SN - 0007-9235

IS - 4

ER -